M
37
6
MRO
54
3
MU
38
2
TRV
45
3
MAC
64
6
EOG
65
3
AN
46
2
GLW
52
4
MDT
59
4
ED
45
-4
PM
50
3
HCP
58
2
DIS
52
4
PCG
75
5
GT
46
5
WMT
62
3
MTCH
35
4
BWA
60
3
PFE
21
3
GOOGL
59
3
M
37
6
MRO
54
3
MU
38
2
TRV
45
3
MAC
64
6
EOG
65
3
AN
46
2
GLW
52
4
MDT
59
4
ED
45
-4
PM
50
3
HCP
58
2
DIS
52
4
PCG
75
5
GT
46
5
WMT
62
3
MTCH
35
4
BWA
60
3
PFE
21
3
GOOGL
59
3
Financhill
Back

XTL Biopharmaceuticals Vs. Insmed Industry Stock Comparison

Sell
24

XTLB
XTL Biopharmaceuticals

Last Price:
2.35
Seasonality Move:
-1.36%
Buy
65

INSM
Insmed

Last Price:
72.22
Seasonality Move:
4.27%
Sell
24
XTL Biopharmaceuticals (XTLB) is a Sell

Is XTL Biopharmaceuticals a Buy, Sell or Hold?

  • The current XTL Biopharmaceuticals [XTLB] share price is $2.35. The Score for XTLB is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • XTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Insmed (INSM) is a Buy

Is Insmed a Buy, Sell or Hold?

  • The current Insmed [INSM] share price is $72.28. The Score for INSM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XTLB Stock Price Chart

What is XTL Biopharmaceuticals's stock price today?

  • The XTL Biopharmaceuticals share price today is $2.35
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTLB is experiencing selling pressure, which indicates risk of future bearish movement.

INSM Stock Price Chart

What is Insmed's stock price today?

  • The Insmed share price today is $72.28
    The current trend is moderately bearish and INSM is experiencing slight buying pressure.

XTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 39.62 Sell
Chaikin Money Flow: -1160 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.41 - 2.67) Sell
Bollinger Bands (100): (2.33 - 2.75) Sell

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 46.34 Sell
Chaikin Money Flow: 515638 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.86 - 74.32) Sell
Bollinger Bands (100): (51.81 - 81.07) Buy

XTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.45 Sell
20-day SMA: 2.5 Sell
50-day SMA: 2.62 Sell
200-day SMA: 2.07 Buy
8-day EMA: 2.42 Sell
20-day EMA: 2.49 Sell
50-day EMA: 2.55 Sell
200-day EMA: 2.18 Buy

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.58 Sell
20-day SMA: 72.92 Sell
50-day SMA: 73.99 Sell
200-day SMA: 47.03 Buy
8-day EMA: 72.53 Sell
20-day EMA: 73.04 Sell
50-day EMA: 71.92 Buy
200-day EMA: 53.13 Buy

XTL Biopharmaceuticals Earnings Growth & XTLB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Insmed Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $1.08 per share.

XTL Biopharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Insmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):